An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations (Q27685255)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Omid Vafa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Gary L Gilliland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Brandy Strake

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Teresa Wilkinson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Eilyn R Lacy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Bernard Scallon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Thomas J Malia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

William R Strohl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

17 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

114-126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

When binding is enough: nonactivating antibody formats.

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Molecular engineering and design of therapeutic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Localization of the binding site for the human high-affinity Fc receptor on IgG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Antibody therapeutics: isotype and glycoform selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

IgG2m4, an engineered antibody isotype with reduced Fc function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Crystal structure of the human IgG4 C(H)3 dimer reveals the role of Arg409 in the mechanism of Fab-arm exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Structural characterization of a human Fc fragment engineered for lack of effector functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Revisiting the role of glycosylation in the structure of human IgG Fc.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Improving biosensor analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

An automated microseed matrix-screening method for protein crystallization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Microseed matrix screening to improve crystals of yeast cytosine deaminase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Promoting crystallization of antibody-antigen complexes via microseed matrix screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Phasercrystallographic software

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Refinement of macromolecular structures by the maximum-likelihood method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Coot: model-building tools for molecular graphics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

7 January 2021

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

The covalent structure of an entire gammaG immunoglobulin molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Engineered antibody Fc variants with enhanced effector function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Aglycosylated chimeric mouse/human IgG1 antibody retains some effector function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Structural Basis for Fc RIIa Recognition of Human IgG and Formation of Inflammatory Signaling Complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

The structure of a human type III Fcgamma receptor in complex with Fc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Engineered antibodies with increased activity to recruit complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Modulation of the effector functions of a human IgG1 through engineering of its hinge region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Amino acid differences in the N-terminus of C(H)2 influence the relative abilities of IgG2 and IgG3 to activate complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Activation of human complement by totally human monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Complement activation plays a key role in antibody-induced infusion toxicity in monkeys and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

In vitro characterization of five humanized OKT3 effector function variant antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

A humanized monovalent CD3 antibody which can activate homologous complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Human IgG2 can form covalent dimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Structural and functional characterization of disulfide isoforms of the human IgG2 subclass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Human IgG2 antibodies display disulfide-mediated structural isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.06.035

10.1016/J.YMETH.2013.06.035

7 January 2021

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23872058%20AND%20SRC:MED&resulttype=core&format=json